Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6841fb2551158db20dd830adcc5fe1f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79441b863b09c9440bfad45c8bb17993 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785 |
filingDate |
1999-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2001-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a787d28a986477285924fa4fd66d238c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffa207c8667b3ba419a87041558a9f1d |
publicationDate |
2001-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6231847-B1 |
titleOfInvention |
Method of treating vascular proliferative responses |
abstract |
This invention relates to a method of treating vascular proliferative responses in a patient that comprises intravenously administering to the patient a proliferative response inhibiting amount of poly(arginine). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005192210-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006167402-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7557087-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1504778-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6605115-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003114360-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004074504-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007185203-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1504778-A3 |
priorityDate |
1997-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |